Pfizer is latest to overhaul DEI goals after GSK (PFE:NYSE)

MT HANNACH
0 Min Read
Disclosure: This website may contain affiliate links, which means I may earn a commission if you click on the link and make a purchase. I only recommend products or services that I personally use and believe will add value to my readers. Your support is appreciated!

Pfizer COVVI-19 vaccine data show an effective rate of 90%

David Dee Delgado

Pfizer (NYSE:Pfe) has made important updates to its diversity, equity and inclusion web page (DEI), becoming the last large large phase after GSK (NYSE:GSK) to revise DEI initiatives in the Trump administration measures to discourage diversity programs.

The major American pharmaceutical

Share This Article
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *